Literature DB >> 21883906

Former smoking is a risk factor for chronic kidney disease after lung transplantation.

M E Hellemons1, P K Agarwal, W van der Bij, E A M Verschuuren, D Postmus, M E Erasmus, G J Navis, S J L Bakker.   

Abstract

Chronic kidney disease (CKD) is a common complication after lung transplantation (LTx). Smoking is a risk factor for many diseases, including CKD. Smoking cessation for >6 months is required for LTx enlistment. However, the impact of smoking history on CKD development after LTx remains unclear. We investigated the effect of former smoking on CKD and mortality after LTx. CKD was based on glomerular filtration rate (GFR) ((125) I-iothalamate measurements). GFR was measured before and repeatedly after LTx. One hundred thirty-four patients never smoked and 192 patients previously smoked for a median of 17.5 pack years. At 5 years after LTx, overall cumulative incidences of CKD-III, CKD-IV and death were 68.5%, 16.3% and 34.6%, respectively. Compared to never smokers, former smokers had a higher risk for CKD-III (hazard ratio [HR] 95% confidence interval [95%CI]= 1.69 [1.27-2.24]) and IV (HR = 1.90 [1.11-3.27]), but not for mortality (HR = 0.99 [0.71-1.38]). Adjustment for potential confounders did not change results. Thus, despite cessation, smoking history remained a risk factor for CKD in LTx recipients. Considering the increasing acceptance for LTx of older recipients with lower baseline renal function and an extensive smoking history, our data suggest that the problem of post-LTx CKD may increase in the future. ©2011 The Authors Journal compilation
© 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883906     DOI: 10.1111/j.1600-6143.2011.03701.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

1.  Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

Authors:  Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos
Journal:  J Heart Lung Transplant       Date:  2021-07-24       Impact factor: 13.569

Review 2.  Hypoxia: The Force that Drives Chronic Kidney Disease.

Authors:  Qiangwei Fu; Sean P Colgan; Carl Simon Shelley
Journal:  Clin Med Res       Date:  2016-02-04

3.  Cigarette smoking and risk of albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies.

Authors:  Haili Xu; Jinliu Suo; Jing Lian
Journal:  Int Urol Nephrol       Date:  2018-02-23       Impact factor: 2.370

Review 4.  Malignancies after lung transplantation.

Authors:  Anne Olland; Pierre-Emmanuel Falcoz; Gilbert Massard
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 5.  Acute kidney injury after lung transplantation: a narrative review.

Authors:  Lei Jing; Wenhui Chen; Lijuan Guo; Li Zhao; Chaoyang Liang; Jingyu Chen; Chen Wang
Journal:  Ann Transl Med       Date:  2021-04

6.  Cigarette smoking reduced renal function deterioration in hypertensive patients may be mediated by elevated homocysteine.

Authors:  Feifei Huang; Jie Chen; Xun Liu; Feng Han; Qingqing Cai; Guicheng Peng; Kun Zhang; Weiqing Chen; Jingfeng Wang; Hui Huang
Journal:  Oncotarget       Date:  2016-12-27

7.  High prevalence of falsely declaring nicotine abstinence in lung transplant candidates.

Authors:  Tobias Veit; Dieter Munker; Gabriela Leuschner; Carlo Mümmler; Alma Sisic; Teresa Kauke; Christian Schneider; Michael Irlbeck; Sebastian Michel; Daniela Eser-Valerie; Maximilian Huber; Jürgen Barton; Katrin Milger; Bruno Meiser; Jürgen Behr; Nikolaus Kneidinger
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.